SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: The BayWatcher who wrote (82)3/12/1997 1:18:00 AM
From: tom dooly   of 354
 
You all have some great posts!

I do not think Abbott has any desire to buy NABI. Abbott is a very conservative pharmaceutical company and I think the idea of owning any company whose primary products involve blood is not an area they particularly are interested in.

Also, I'm not sure if NABI and Abbott are particularly close now. Abbott just recently just stopped making NABI's H-BIG. This is to be transferred to some Michigan facilities and later to be made also in their new Boca Raton facility.

Further, I don't believe NABI wants to be acquired. I think they have their own plans! A hostile takeover is possible but not likely.

I recommend you buy USRX rather than COMS. If you take the COMS closing price of $35.25 times 1.75 (exchange ratio in merger), USRX should be selling for $61.68, however, USRX closed @ $59.50. I also don't think you will be able to pick up COMS for less than $33/share. In fact, it may have turned and you may not be able to get it for that.

I think NABI is going up, but it may test our patience doing it!

Also, keep one eye on SNUS. I just played with what I consider some consevative calculations and I can easily see $500/share within the next 5 years. SNUS is now going through a few very critical months in the final stages of FDA approval.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News